Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To identify the core gut microbial features associated with type 2 diabetes risk and potential demographic, adiposity, and dietary factors associated with these features. RESEARCH DESIGN AND METHODS: We used an interpretable machine learning framework to identify the type 2 diabetes–related gut microbiome features in the cross-sectional analyses of three Chinese cohorts: one discovery cohort (n = 1,832, 270 cases of type 2 diabetes) and two validation cohorts (cohort 1: n = 203, 48 cases; cohort 2: n = 7,009, 608 cases). We constructed a microbiome risk score (MRS) with the identified features. We examined the prospective association of the MRS with glucose increment in 249 participants without type 2 diabetes and assessed the correlation between the MRS and host blood metabolites (n = 1,016). We transferred human fecal samples with different MRS levels to germ-free mice to confirm the MRS–type 2 diabetes relationship. We then examined the prospective association of demographic, adiposity, and dietary factors with the MRS (n = 1,832). RESULTS: The MRS (including 14 microbial features) consistently associated with type 2 diabetes, with risk ratio for per 1-unit change in MRS 1.28 (95% CI 1.23–1.33), 1.23 (1.13–1.34), and 1.12 (1.06–1.18) across three cohorts. The MRS was positively associated with future glucose increment (P < 0.05) and was correlated with a variety of gut microbiota–derived blood metabolites. Animal study further confirmed the MRS–type 2 diabetes relationship. Body fat distribution was found to be a key factor modulating the gut microbiome–type 2 diabetes relationship. CONCLUSIONS: Our results reveal a core set of gut microbiome features associated with type 2 diabetes risk and future glucose increment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Type 2 Diabetes Obesity is the most important risk factor for type 2 diabetes (27).”
BackgroundZhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 2×
“Specially, lactobacillus species had the highest score for the identification of patients with type 2 diabetes in a European study (36).”
BackgroundMethodGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 3×
“In addition, we validated the identified MRS–type 2 diabetes relationship in two independent human cohorts and germ-free mice, which has rarely been achieved in prior studies (5,34,35,38).”
MethodResultBig Data and Machine Learning in Health Care
Beam, A. L., & Kohane, I. S. (2018) · JAMA · doi:10.1001/jama.2017.18391 · Cited by 2,506 · cited 1×
“Machine learning has been widely used in biomedical fields in recent years (6).”
BackgroundPopulation-level analysis of gut microbiome variation
Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., Kurilshikov, A., Bonder, M. J., Valles-Colomer, M., Vandeputte, D., et al. (2016) · Science · doi:10.1126/science.aad3503 · Cited by 2,400 · cited 1×
“On the other hand, multiple host anthropometric, dietary, and lifestyle factors play important roles in shaping the microbiome composition (29), while large human cohorts that take into account these confounders are necessary but are thus far sparse.”
BackgroundHuman gut microbes impact host serum metabolome and insulin sensitivity
Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., et al. (2016) · Nature · doi:10.1038/nature18646 · Cited by 2,116
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539 · cited 1×
“The roseburia, which was decreased in our patients with type 2 diabetes, is a butyrate-producing genus and has been shown to causally improve glucose tolerance (31,32).”
BackgroundConsistent Individualized Feature Attribution for Tree Ensembles
Lundberg, S. M., Erion, G. G., & Lee, S.-I. (2018) · arXiv · doi:10.48550/arxiv.1802.03888 · Cited by 1,430
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931
Regional variation limits applications of healthy gut microbiome reference ranges and disease models
He, Y., Wu, W., Zheng, H.-M., Li, P., McDonald, D., Sheng, H.-F., Chen, M.-X., Chen, Z.-H., Ji, G.-Y., Zheng, Z.-D.-X., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0164-x · Cited by 894 · cited 3×
“GGMP (10) was conducted between 2015 and 2016; 7,009 participants (608 case subjects, 530 fasting blood glucose $7.0 mmol/L) with measurement of 16S rRNA from stool samples were included in the current study.”
MethodInfluentialSelf-citationMicrobiota and diabetes: an evolving relationship
Tilg, H., & Moschen, A. R. (2014) · Gut · doi:10.1136/gutjnl-2014-306928 · Cited by 853 · cited 1×
“Gut microbiome is considered as a modifiable environmental factor that plays an important role in the development of type 2 diabetes (3).”
BackgroundThe gut microbiota modulates host energy and lipid metabolism in mice
Velagapudi, V. R., Hezaveh, R., Reigstad, C. S., Gopalacharyulu, P., Yetukuri, L., Islam, S., Felin, J., Perkins, R., Borén, J., Orešič, M., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m002774 · Cited by 589
Risk models and scores for type 2 diabetes: systematic review
Noble, D., Mathur, R., Dent, T., Meads, C., & Greenhalgh, T. (2011) · BMJ · doi:10.1136/bmj.d7163 · Cited by 551 · cited 1×
“A total of 297 host features that were potentially related to type 2 diabetes in the literature (metadata, gut microbiota composition, and diversity [see Supplementary Material]) (15) were incorporated into our machine learning model.”
BackgroundT cell-mediated regulation of the microbiota protects against obesity
Petersen, C., Bell, R., Klag, K. A., Lee, S.-H., Soto, R., Ghazaryan, A., Buhrke, K., Ekiz, H. A., Ost, K. S., Boudina, S., et al. (2019) · Science · doi:10.1126/science.aat9351 · Cited by 385 · cited 3×
“In addition, we validated the identified MRS–type 2 diabetes relationship in two independent human cohorts and germ-free mice, which has rarely been achieved in prior studies (5,34,35,38).”
BackgroundMethodExposing the exposures responsible for type 2 diabetes and obesity
Franks, P. W., & McCarthy, M. I. (2016) · Science · doi:10.1126/science.aaf5094 · Cited by 265
Cited by
Gut microbial carbohydrate metabolism contributes to insulin resistance
Takeuchi, T., Kubota, T., Nakanishi, Y., Tsugawa, H., Suda, W., Kwon, A. T.-J., Yazaki, J., Ikeda, K., Nemoto, S., Mochizuki, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06466-x · Cited by 438
Machine Learning and Artificial Intelligence in the Multi-Omics Approach to Gut Microbiota
Rozera, T., Pasolli, E., Segata, N., & Ianiro, G. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.035 · Cited by 112
Chen, Y., Wang, H., Lu, W., Wu, T., Yuan, W., Zhu, J., Lee, Y. K., Zhao, J., Zhang, H., & Chen, W. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2025016 · Cited by 94
“18 21 Therefore, after deconvoluting the effect of regional factors, we made a systematic comparison between multiple heterogeneous model algorithms, in which each regressor was widely used in metagenomic data analysis.”
BackgroundArtificial intelligence & clinical nutrition: What the future might have in store
Bond, A., Mccay, K., & Lal, S. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.07.082 · Cited by 79
Abavisani, M., Khoshrou, A., Foroushan, S. K., Ebadpour, N., & Sahebkar, A. (2024) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2024.100211 · Cited by 75
Metadata
- Authors
- Gou, W., Ling, C.-W., He, Y., Jiang, Z., Fu, Y., Xu, F., Miao, Z., Sun, T.-Y., Lin, J.-S., Zhu, H.-L., Zhou, H., Chen, Y.-M., & Zheng, J.-S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-12-07
- Volume
- 44
- Issue
- 2
- Pages
- 358-366
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3113237873
- Cited by
- 174
- References
- 20
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.